Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
ThermoGenesis Cool-Off Should Be Short-LivedMike Havrilla • Tue, Jul 3, 2007
-
-
Thermogenesis Increases Production of Cord Blood Stem Cell BagsH.S. Ayoub • Sun, Mar 4, 2007
-
Thermogenesis Trips on Manufacturing Capacity BumpH.S. Ayoub • Mon, Feb 12, 2007
-
Thermogenesis Answers FDA about CryoSeal SystemH.S. Ayoub • Wed, Feb 7, 2007
-
Thermogenesis Corp. Doubles Revenue, Cuts LossH.S. Ayoub • Thu, Nov 9, 2006
-
Thermogenesis Positioned For Cryopreservation Market GrowthH.S. Ayoub • Mon, Oct 9, 2006
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
Regenerative Medicine Universe Earnings Report Card Q3/11Henry McCusker • Fri, Nov 11, 2011 -
Post Excessive Sell-Off, September Is Still In The WindHenry McCusker • Tue, Aug 30, 2011
-
-
-
-
-
-
-
-
-
GE Healthcare, Heads Up: Thermogenesis Would Make A Great BuyH.S. Ayoub • Tue, May 22, 2007
-
-
Investing in Cord Blood: ThermoGenesis, Cryo-Cell, ViaCell and CelgeneStockerblog • Thu, Mar 15, 2007
-
-
-
StemCells Shares Jump On Clinical Trial NewsH.S. Ayoub • Thu, Nov 16, 2006
-
Thermogenesis' CEO Discusses F1Q13 Results - Earnings Call TranscriptTue, Nov 13, 2012
-
ThermoGenesis' CEO Discusses F4Q12 Results - Earnings Call TranscriptThu, Sep 20, 2012
-
ThermoGenesis Corp. F4Q08 (Qtr End 06/30/08) Earnings Call TranscriptTue, Sep 9, 2008 • 1 Comment
-
GlobeNewswire (Wed, 8:00AM)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 7, 2013)
-
GlobeNewswire (Apr 1, 2013)
-
GlobeNewswire (Mar 28, 2013)
-
GlobeNewswire (Mar 14, 2013)
-
GlobeNewswire (Feb 12, 2013)
-
GlobeNewswire (Feb 5, 2013)
-
GlobeNewswire (Jan 3, 2013)
-
GlobeNewswire (Nov 13, 2012)
-
GlobeNewswire (Nov 7, 2012)
-
GlobeNewswire (Sep 20, 2012)
-
GlobeNewswire (Sep 19, 2012)
-
GlobeNewswire (Sep 14, 2012)
-
GlobeNewswire (Sep 14, 2012)
-
GlobeNewswire (Sep 7, 2012)
-
GlobeNewswire (Sep 4, 2012)
-
GlobeNewswire (Aug 22, 2012)
-
at Fox Business (Aug 20, 2012)
-
at Fox Business (Aug 20, 2012)
KOOL vs. ETF Alternatives
Company Description
Our mission is to design, develop and commercialize medical products that enable the collection, processing and cryopreservation of stem cells and other cellular tissues used in the practice of regenerative medicine. Regenerative medicine is an emerging field that, among other things, aims to... More
